Marcan Pharmaceuticals to invest CAD $50 million in Mantra Pharma Inc.

India, July 6 -- Emcure Pharmaceuticals announced that Marcan Pharmaceuticals Inc., a subsidiary of the Company (Marcan) has on 02 July 2026 (EDT) entered into share purchase agreements with certain shareholders of Mantra Pharma Inc., a step-down subsidiary of the Company (Mantra), to acquire all of Class E Special Shares in the share capital of Mantra for an aggregate consideration of CAD $ 50 million. Consequently, Mantra continues to be 100% subsidiary of Marcan.Mantra Pharma Inc., a company incorporated under the laws of Quebec, Canada, is engaged in the marketing and distribution of prescription drugs and natural health products.

Published by HT Digital Content Services with permission from Pivotal Sources....